C-terminal amino acids are essential for human heat shock protein 70 dimerization by Marcion, Guillaume et al.
C-terminal amino acids are essential for human heat
shock protein 70 dimerization
Guillaume Marcion, Renaud Seigneuric, Evelyne Chavanne, Yves Artur, Lo¨ıc
Briand, Tarik Hadi, Jessica Gobbo, Carmen Garrido, Fabrice Neiers
To cite this version:
Guillaume Marcion, Renaud Seigneuric, Evelyne Chavanne, Yves Artur, Lo¨ıc Briand, et al..
C-terminal amino acids are essential for human heat shock protein 70 dimerization. Cell Stress
and Chaperones, Springer Verlag, 2014, 20 (1), pp.61-72. <10.1007/s12192-014-0526-3>. <hal-
01187031v1>
HAL Id: hal-01187031
https://hal.archives-ouvertes.fr/hal-01187031v1
Submitted on 5 Sep 2015 (v1), last revised 11 Jan 2015 (v2)
HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.
L’archive ouverte pluridisciplinaire HAL, est
destine´e au de´poˆt et a` la diffusion de documents
scientifiques de niveau recherche, publie´s ou non,
e´manant des e´tablissements d’enseignement et de
recherche franc¸ais ou e´trangers, des laboratoires
publics ou prive´s.
ORIGINAL PAPER
C-terminal amino acids are essential for human heat shock
protein 70 dimerization
Guillaume Marcion & Renaud Seigneuric & Evelyne Chavanne & Yves Artur &
Loïc Briand & Tarik Hadi & Jessica Gobbo & Carmen Garrido & Fabrice Neiers
Received: 17 April 2014 /Revised: 3 July 2014 /Accepted: 4 July 2014
# The Author(s) 2014. This article is published with open access at Springerlink.com
Abstract The human inducible heat shock protein 70
(hHsp70), which is involved in several major pathologies,
including neurodegenerative disorders and cancer, is a key
molecular chaperone and contributes to the proper protein
folding and maintenance of a large number of protein struc-
tures. Despite its role in disease, the current structural knowl-
edge of hHsp70 is almost exclusively based on its Escherichia
coli homolog, DnaK, even though these two proteins only
share ~50 % amino acid identity. For the first time, we de-
scribe a complete heterologous production and purification
strategy that allowed us to obtain a large amount of soluble,
full-length, and non-tagged hHsp70. The protein displayed
both an ATPase and a refolding activity when combined to
the human Hsp40. Multi-angle light scattering and bio-layer
interferometry analyses demonstrated the ability of hHsp70 to
homodimerize. The role of the C-terminal part of hHsp70 was
identified and confirmed by a study of a truncated version of
hHsp70 that could neither dimerize nor present refolding
activity.
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Abbreviations
hHsp70 human heat shock protein 70
hHsp40 human heat shock protein 40
NBD nucleotide binding domain
SBD substrate binding domain
BLI Bio-Layer Interferometry
SEC size exclusion chromatography
SEC-MALS size exclusion chromatography
multi-angle light scattering
Hsc human heat shock cognate protein
Introduction
Molecular chaperones assist in the non-covalent folding or
unfolding of a polypeptide chain, refolding of misfolded in-
termediates, the assembly or disassembly of a complex, and its
proper localization in the cell (Ellis 1987; Fink 1999; Taipale
et al. 2010). Many cellular proteins tend to aggregate and
become insoluble after a stress such as a heat shock, and the
molecular chaperones that play a role in this process include
members of the heat shock protein (Hsp) family. Hsps are
structurally and functionally diverse proteins and are classified
according to their approximate molecular mass. These pro-
teins include six families: small Hsps, Hsp40, Hsp60, Hsp70,
Hsp90, and Hsp110 (Brodsky and Chiosis 2006; Garrido et al.
2006; Mayer and Bukau 2005; Powers and Workman 2007;
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Schmitt et al. 2006). The human Hsp70 family is encoded by
13 genes members (excluding the pseudogenes) (Brocchieri
et al. 2008). At the protein level, the constitutively-expressed
Hsc70 and the inducible Hsp70 share nearly 80 % amino acid
sequence identity and differ by their C-terminal region
(Dworniczak and Mirault 1987; Jinwal et al. 2013; Maeda
et al. 2007). Present at low or undetectable levels in most
unstressed normal cells and tissues, Hsp70 (also referred to as
Hsp72, Hsp70-1, or HspA1A) is among the most stress-
inducible molecular chaperones (Dworniczak and Mirault
1987; Freeman et al. 1995). This ~70 kDa chaperone interacts
with Hsp40 to accommodate its substrates, binds to short
linear stretches of hydrophobic residues and refolds its sub-
strate properly through cycles of ATP binding, hydrolysis, and
release (Ellis et al. 2007; Schlecht et al. 2011; Taipale et al.
2010). Acting within the chaperone network, Hsp70 is central
in protein folding and homeostasis (Bukau et al. 2000; Hartl
et al. 2011; Hartl and Hayer-Hartl 2002). Human Hsp70
(hHsp70) is involved in several pathologies, including neuro-
degenerative disorders and cancer, where it exerts both a
chaperone and an anti-apoptotic function (Garrido et al.
2001; Hartl et al. 2011; Jaattela 1999; Seigneuric et al.
2011b). The modulation of hHsp70 activity may thus repre-
sent an interesting therapeutic approach for some of these
pathologies (Calderwood 2010, 2013; Gobbo et al. 2011;
Jego et al. 2010; Seigneuric et al. 2011a; Stangl et al. 2011).
Despite the importance and relevance of hHsp70 in health and
disease, the most mechanistic information has been inferred
from comparisons with its bacterial homolog, DnaK
(Bhattacharya et al. 2009; Kityk et al. 2012; Kumar et al.
2011; Swain et al. 2007; Taipale et al. 2010; Vogel et al.
2006), despite the fact that human and bacterial Hsp70 share
only ~50 % amino acid sequence identity (Hunt and
Morimoto 1985; Nicolaï et al. 2013; Zhu et al. 1996). The
hHsp70 is divided into two functional domains connected by a
short linker: an amino-terminal nucleotide binding domain
(NBD) and a carboxyl-terminal substrate binding domain
(SBD). Allosteric regulation of hHsp70 between these two
domains remains to be elucidated (Nicolaï et al. 2013). In
addition, there are no full-length structures of the members
of the hHsp70 protein family available, most likely due to the
limited amount of pure available protein and/or technical
challenges. Therefore, current structural representations of
hHsp70 are based on the full-length structure of Escherichia
coli DnaK solved by NMR (PDB ID: 2KHO) (Bertelsen et al.
2009). More recently, full-length E. coliDnaK structures in an
ATP-bound state were solved using X-ray diffraction (PDB
ID: 4B9Q, and 4JNE) (Kityk et al. 2012; Qi et al. 2013). Thus,
most of the information on hHsp70 is derived from the E. coli
Hsp70 homolog DnaK. A few independent studies have re-
vealed a mixture of monomeric and dimeric forms after puri-
fication, but the in vivo relevance of these forms is a debatable
point (Palleros et al. 1993; Richarme and Kohiyama 1993).
Using electron microscopy, Thompson et al. demonstrated
that a DnaK mixture of dimer and monomer led to
monomerization following substrate addition (Thompson
et al. 2012).With regards to hHsp70, different groups reported
the existence of oligomeric states frommonomer to high order
oligomers (Angelidis et al. 1999; Aprile et al. 2013; Nemoto
et al. 2006). A variety of mechanisms have been proposed to
explain the change of oligomeric state, including cystein
oxidation-dependence (Nemoto et al. 2006) or temperature
dependency (Angelidis et al. 1999). Recently, an interaction
between the linker and the SBD has been proposed to mediate
the oligomerization of hHsp70 (Aprile et al. 2013). Protein
quantity is still a limiting step for biophysical or structural
studies allowing for the characterization of the oligomeric
state. To date, only commercial hHsp70 (HspA1A), sold by
Stressgen, is available; therefore, the process of purification
remains confidential. The heterologous expression and purifi-
cation of the chaperone family proteins tends to exhibit low
recovery and specificity (Nicoll et al. 2006). Some studies
report a partial purification of hHsp70 fused to another protein
(Macejak et al. 1990) or to a His-tagged protein (Aprile et al.
2013; Nemoto et al. 2006). Moreover, it has been demonstrat-
ed that small N- or C-termini extensions of the rat Hsc70
homolog or hHsp70 may alter their ATPase activities and
peptide binding (Boice and Hightower 1997). In the present
paper, a detailedmethodology allowing for the production of a
large quantity of a recombinant, pure, full-length, and fully
active hHsp70 is described. This approach enabled us to
explore, for the first time, the oligomeric state of a non-
tagged hHsp70 using an improved size exclusion chromatog-
raphy (SEC) technology that can provide an absolute molec-
ular mass: SEC-MALS (multi-angle light scattering). Using
additional biophysical, and biochemical studies, we demon-
strate the molecular basis driving the formation of the ob-
served dimeric state.
Results
Characterization of the full-length hHsp70
and the delta-hHsp70
A synthetic, codon-optimized coding sequence for hHsp70
expression was introduced in a pET21a plasmid. Among the
different cells that were tested for pET21-hHsp70 plasmid
expression, BL21 Star (DE3) presented the highest level of
expression. After transformation and production, the samples
were analyzed by sodium dodecyl sulfate polyacrylamide gel
electrophoresis (SDS-PAGE). Two bands were observed after
induction: an intense band that migrated at approximately
70 kDa (full-length hHsp70) and a second, less intense band
that migrated at approximately 60 kDa (delta-hHsp70)
(Fig. 1a, lane 1).
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Peptide mass fingerprinting, involving tryptic cleavage
combined with MALDI-ToF analysis, confirmed that the
70 kDa protein corresponded to the full-length hHsp70
(Supplemental figure 1 A and C). All peptide fragments
corresponded to hHsp70. This analysis also showed that the
contamination from endogenous DnaK was non-detectable or
absent. Moreover, these fragments covered the entire protein
length.
During production, hHsp70 showed a sensitivity to a spe-
cific proteolysis, resulting in a band localized at approximate-
ly 60 kDa (delta-hHsp70) (Fig. 1, panel a). This band was
observed in all of the different production and purification
batches tested, similar to other studies where Hsp70 was
produced (Gross and Hessefort 1996; Peake et al. 1998).
Mass spectroscopy fingerprinting analysis of this band
showed a panel of peptides originating from hHsp70, thus
proving that the pure protein obtained here corresponds to a
truncated form of the hHsp70. The peptide analysis
(Supplemental figure 1 B and D) revealed the presence of
peptide fragments from the third amino acid residue.
Moreover, none of the fragments were observed after the
K561 amino acid residue, thereby suggesting a protein mass
of 61.4 kDa and a proteolysis cleavage occurring after the
K561 amino acid residue.
Purification of full-length hHsp70 and delta-hHsp70
Protein purity after the different purification steps is shown
in Fig. 1, panel a. After the centrifugation of sonicated
cells, two thirds of the total recombinant hHsp70 was
found in the pellet and one third was found in the
supernatant. Different refolding strategies were carried
out on the inclusion bodies without success because the
resulting soluble protein showed no functional activity in
the tested conditions (data not shown). The soluble hHsp70
obtained after the first centrifugation (supernatant) was
loaded on an anion exchange resin column (DEAE resin).
Interestingly, this step allowed us to separate the two
hHsp70 forms observed after production. Delta-hHsp70
eluted at approximately 0.15 mM KCl, whereas the full-
length hHsp70 eluted at 0.20 M KCl. The latter value is in
agreement with the low theoretical isoelectric pH of 5.5
calculated for the full-length hHsp70. This observation
also suggests a higher value of the isoelectric pH for
delta-hHsp70. A simulated truncation of hHsp70 leading
to a 60 kDa protein showed that only a C-terminal trunca-
tion of the protein increases the isoelectric pH by 0.3 pH
units, whereas an N-terminal truncation decreases this val-
ue by 0.2 pH units. These isoelectric pH differences be-
tween the two forms are also in agreement with the mass
spectroscopy experiment, suggesting a truncation occur-
ring after the K561 residue.
Fractions containing hHsp70 were pooled and loaded onto
a strong anion exchange resin (Q-sepharose resin) followed by
size exclusion chromatography (Superdex 200 Hiload 26/60).
Next, the pooled fractions were reloaded on the strong anion
exchange resin (Q-sepharose resin). Samples of each purifi-
cation step were loaded on a 12.5 % SDS-PAGE (Fig. 1, panel
a). Thirty milligrams of pure hHsp70 was obtained per liter of
culture, corresponding to a purification efficiency of approx-
imately 15 % of the total hHsp70 produced (soluble and non-
soluble).
Fig. 1 Purification of full-length hHsp70 and delta-hHsp70. a Proteins
were separated by 12 % SDS-polyacrylamide gel electrophoresis and
stained with Coomassie blue. The different lanes correspond to cell
pellets 12 h after IPTG induction (lane 1), supernatant after sonication
and centrifugation (lane 2), pool after the DEAE exchange column
chromatography (lane 3), pool after the Q-sepharose exchange column
chromatography (lane 4), pool after the Superdex 200 chromatography
(lane 5), and after the final Q-sepharose exchange column chromatogra-
phy (lane 6). The star and double star indicate full-length hHsp70 and
delta-hHsp70, respectively. b The pool of delta-hHsp70 after the DEAE
exchange column chromatography (lane 1) and after purification on
exclusion chromatography using a Superdex 200 (lane 2) was analyzed
by SDS-PAGE. MW molecular mass markers
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With regards to delta-hHsp70 separated after the first anion
exchange resin column, this protein sample was concentrated
to a 5-mL final volume and loaded on a gel filtration column
(Superdex 200 Hiload 26/60). Again, sample of each purifi-
cation steps were loaded on a 12.5 % SDS-PAGE (Fig. 1,
panel b).
After 12 months, the full-length hHsp70 was again tested
without signs of protein precipitation. Further, its folding
activity was similar to the freshly produced protein, thereby
suggesting that long-term storage did not alter the chaperone
activity.
Intrinsic tryptophan fluorescence emission
To check the quality of the full-length hHsp70, we recorded its
tryptophan (Trp) fluorescence emission spectrum before and
after denaturation with two concentrations of guanidine chlo-
ride. To select a typical Trp fluorescence emission, a 295-nm
excitation wavelength was used. Full-length hHsp70 contains
two Trp (amino acid position 90 and 580). The maximum
emission fluorescence signal due to the Trp90 and Trp580
amino acid residues at 349 nm supports their polar environ-
ment location (Fig. 2). After being exposed to a 2- and 4-M
guanidine chloride solution, the full-length hHsp70 maximum
emission spectra (at 354 and 356 nm, respectively) presented a
red shift compared to the non-denatured protein, typical of an
increased solvent exposure (Fig. 2). The red shift and the
observed maximum emission intensity decrease demonstrated
a full-length hHsp70 denaturation. The observations support
that the protein was initially properly folded in the starting
solution before denaturation.
Secondary structure analysis of recombinant full-length
hHsp70 and delta-hHsp70
To confirm the folding of full-length hHsp70 and delta-
hHsp70, we carried out circular dichroïsm spectrophotometer
analysis. The recorded signals between 188 and 260 nm were
superposed (Fig. 3). The good correlation of the two spectra
supports a similar folding of the full-length and truncated
hHsp70 forms. The far-UV spectra of the two proteins
displayed a positive peak centered at 193 nm and two negative
peaks at 210 and 218 nm, showing the helical character of
both proteins. The deconvolution of the circular dichroïsm
(CD) spectra revealed that the full-length hHsp70 was com-
posed of approximately 50–60 % alpha-helix and 25–30 %
beta-sheet, whereas the truncated form revealed 40–50 %
alpha-helix and 50 % beta-sheet.
Oligomeric state analysis of recombinant full-length hHsp70
and delta-hHsp70
Using size exclusion chromatography (SEC) coupled to re-
fraction index and multi-angle light scattering detectors
(MALS), we determined the oligomeric state of full-length
hHsp70 and delta-hHsp70. The three light scattering detectors
exhibited a superposed signal characteristic of a monodisperse
protein for both proteins. A single peak suggested homoge-
nous samples in both cases (Fig. 4a, b). This last observation
supports the notion that proteolysis occurs with a single cleav-
age resulting in delta-hHsp70. Moreover, the SEC-MALS
spectra analysis showed a low percentage of aggregated forms
(less than 1 %) for both proteins. This last observation sup-
ports the fact that the samples were properly folded and stable.
The recombinant full-length hHsp70 data analysis showed
a single peak with a calculated mass from the MALS exper-
iment of 139 kDa, corresponding to a hHsp70 dimer. The
Fig. 2 Fluorescence emission spectra of full-length hHsp70 with or
without denaturation. The spectra of 5 μM protein were measured in
20 mM Tris–HCl pH 8.0 buffer (solid curve), in the same buffer supple-
mented with 2 M of guanidine chloride (dotted curve), or in 4 M of
guanidine chloride (dashed curve). After excitation at 295 nm, the mea-
sured maximum emission spectra were 349, 354, and 356 nm (red shift),
respectively, while the maximum of fluorescence emission spectra de-
creased. One representative curve is shown (n=4)
Fig. 3 Secondary structure analysis by circular dichroism. Spectra of the
full-length hHsp70 (solid curve, left axis) and delta-hHsp70 (dashed
curve, right axis) are presented in molar ellipticity (deg.cm2.dmol−1).
The spectra were recorded at 20 °C in a 0.01-cm path cell length with a
5-μM protein concentration in a 20-mM Tris–HCl pH 8.0 buffer
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theoretical mass for a dimer is estimated at 140 kDa
(Fig. 4a, b).
The molecular mass of delta-hHsp70 estimated by aMALS
instrument was 59 kDa, thus suggesting a monomeric state of
the protein. These data were in agreement with the results
obtained by SDS-PAGE and mass spectroscopy fingerprint-
ing, thereby suggesting the following: (i) a molecular mass of
approximately 60 kDa and (ii) the homogeneity of the sample
supports a single cleavage site leading to truncated hHsp70.
The absence of major structural modifications between the
full-length protein in the dimeric state and the truncated form
in the monomeric state, as demonstrated by circular dichro-
ism, suggest no major structural changes during the dimeriza-
tion process. To further demonstrate the existence of a
hHsp70:hHsp70 interaction, we have quantified the following
protein-protein interactions: (1) hHsp70:hHsp70, (2)
hHsp70:hHsp40, and (3) DnaK:DnaKwith another technique:
the Bio-Layer Interferometry (BLI). BLI is an optical- and
label-free technique sensitive to an increase of mass bound to
a biosensor (e.g., bound analyte). BLI provides sensorgrams
like surface plasmon resonance. To perform the experiment,
after biotynilation of hHsp70, the protein was immobilized
onto the biosensor tip. Then, we tested the ability of hHsp70
to interact with hHsp70 in solution. These results clearly
demonstrate that hHsp70 is interacting with hHsp70 in solu-
tion, demonstrating the capacity of hHsp70 to dimerize. The
technique allows observing the small fraction of dimer ex-
changing their partner (supported by the 1:1 model fitting the
sensograms). Moreover, hHsp70 presents a high-affinity in the
low nanomolar range for itself in agreement with the ranges
observed for dimers (KD ~5 nM, Fig. 4c). We also show that,
the well-known hHsp70:hHsp40 interaction has a greater af-
finity (KD ~0.5 nM, Fig. 4d). Also, in line with the literature
collated in Table 1, we confirm the DnaK:DnaK interaction
(Fig. 4e), as a positive control of this experiment. Its affinity
compares to the hHsp70:hHsp70 interaction (KD ~5 nM).
In another BLI experiment, we used a previously selected
peptide aptamer (A17) arising from a screen for its ability to
bind to the N-terminal domain of hHsp70 (Rerole et al. 2011).
As shown in Fig. 5, the measured signal shows a binding of
Fig. 4 Oligomeric state analysis of hHsp70. After size exclusion chro-
matography (SEC) and separation with a suitable chromatography col-
umn (MP015S5 column from Wyatt for delta-hHsp70, and MP030S5
column from Wyatt for the full-length hHsp70), the molecular mass was
determined from the Raleigh ratio, measured by static light scattering and
the refractive index. The calculated molecular mass (bold black curve),
refraction index (dotted black curve), and light scattering (black curve)
are shown. The computedmolecular masses are as follows: 139 kDa (full-
length hHsp70: dimer) (a), and 59 kDa (delta-hHsp70: monomer) (b). c,
d, and e Sensorgrams were obtained by Bio-Layer Interferometry (BLI).
The different concentrations of the analytes in PBS are: panel c hHsp70
(1: 200, 2: 300, 3: 400, and 4: 500 nM); panel d hHsp40 (1: 20, 2: 30, 3:
40, and 4: 50 nM); and panel e DnaK (1: 200, 2: 300, 3: 400 and 4:
500 nM). The best fit is provided with the 1:1 model (red fit) with a KD
value of 4.5 +/− 0.1 nM, a r2 of 0.99 for hHsp70:hHsp70 (c), a KD value
of 0.52 +/− 0.01 nM, a r2 of 0.99 for hHsp70:hHsp40 (d), and a KD value
of 5.4 +/− 0.2 nM, a r2 of 0.99 for DnaK:DnaK (e)
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hHsp70 with the A17 peptide aptamer. This binding is only fit
by a 1:2 (A17: hHsp70×2) binding model with a KD in the
low nM range. It corresponds to the affinity of the hHsp70 (as
a homodimer) for the A17 peptide aptamer. This result sup-
ports that the protein is properly folded. Also, it indirectly
shows, by this third method, the dimeric state of the protein.
Interestingly, in contrast to the A17:hHsp70 interaction, the
A17:DnaK interaction is quite weak (around 6 nM compared
to 50 nM, respectively, Fig. 5). This further demonstrates the
specificity of the A17 ligand for hHsp70.
Functional assay
Two aspects of hHsp70 function, ATPase activity and
refolding activity were monitored.
ATPase activity was assessed by a homogeneous time-
resolved fluorescence technique (HTRF) that follows the per-
centage ofATP to ADP enzymatic hydrolysis. The bar diagram
represents the percentage of converted ATP (Fig. 6a): with no
proteins (NP), with native firefly luciferase (NL), or with
denatured firefly luciferase (DL) in a refolding buffer contain-
ing either no Hsps, our full-length hHsp70 alone, or with
hHsp40. This data demonstrates the ATPase activity of
hHsp70 compared to hHsp40. Moreover, this activity was
dramatically increased in combination with its natural co-
chaperone, hHsp40. Adding a native client protein increased
this ATPase activity that was further increased when the client
protein is denatured. This result demonstrates the active state of
the purified protein and its efficient coupling to human Hsp40.
The refolding activity of the recombinant full-length
hHsp70 and delta-hHsp70 proteins was then measured by
their ability to refold a denatured firefly luciferase protein. In
this colorimetric assay, different types of Hsp70 are combined,
one at a time, with a human Hsp40. The refolding percentage
is compared to the positive (non-denatured, thus luminescent
firefly luciferase) and negative (denatured, thus non-
Table 1 Studies detailing the oligomerization status of different Hsp70 family members along with the method used to determine the status
Hsp70 family Quaternary structure/Oligomerization form (method) Domain involved
DnaK (E coli) Monomer (SEC-LS) (Kityk et al. 2012) n.a.
Monomer, mainly dimer, possibly trimer (SAXS, SEC) (Shi et al. 1996) n.a.
Forms monomers, dimers and higher molecular mass oligomers
(DLS, SEC, native and SDS-PAGE) (Schonfeld et al. 1995)
An ensemble of monomers, dimers, and other small defined multimers
(cross-linking, EM, native, and SDS-PAGE) (Thompson et al. 2012)
BiP (M. musculus) Monomer, dimer, and trimer (native PAGE) (Blond-Elguindi et al. 1993) n.a.
Hsc70 (rat) Monomer to at least trimer (cross-linking, native PAGE, SEC) (Benaroudj et al. 1995) n.a.
Monomer, dimer, and/or trimer (SEC) (Benaroudj et al. 1996) n.a.
Monomer and oligomer (SDS-PAGE, SEC) (Benaroudj et al. 1997) Oligomer,
probably tetramer (SEC) (Fouchaq et al. 1999)
C-terminal
Hsc70 (H. sapiens) Monomer, dimer, and trimer (cross-linking) (Kim et al. 1992) n.a.
Hsp70 (H. sapiens) HSP70 and HSC70 can form monomers, dimers, and oligomers (SDS-PAGE) (Angelidis et al. 1999) n.a.
Monomeric, dimeric, trimeric, and presumably oligomeric species (SEC, native and SDS-PAGE)
(Nemoto et al. 2006)
C-terminal
Forms monomers, dimers, trimers, and tetramers (DLS, SEC) (Aprile et al. 2013) Linker+C-terminal SBD
DLS dynamic light scattering,EM electron microscopy, LS light scattering,PAGE polyacrylamide gel electrophoresis, SAXS small angle x-ray scattering,
SBD substrate binding domain, SDS sodium dodecyl sulfate, SEC size exclusion chromatography, n.a. not available
Fig. 5 Sensorgrams representing the interaction between hHsp70 and the
Hsp70 peptide aptamer A17. In contrast to the capture of hHsp70 at
100 nM with peptide aptamer A17 (dark blue sensorgram), the bottom
sensorgram obtained by Bio-Layer Interferometry (BLI) (light blue) indi-
cates that A17 and DnaK hardly interact. This stresses the actual differ-
ences in the N-terminal region of hHsp70 and DnaK, although this region
is largely considered as well conserved. A17:DnaK binding fits with a 1:1
model (not excluding a 1:2 model) and A17:hHsp70 with 1:2 model
(excluding the simplest 1:1 model). An estimation of the KD is in the
50 nM range for A17:DnaK whereas an estimation of the KD of
A17:hHsp70 is around 6 nM
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luminescent firefly luciferase, without Hsp70) controls. In
order to monitor refolding following denaturation, different
kinetics (60 min, 120 min, 180 min) were investigated (data
not shown). The best condition was obtained after a 180 min
of refolding kinetics and used for all conditions. The Pareto
plot (bar diagram in descending order) in Fig. 6b indicates that
the full-length and non-tagged hHsp70 produced here present-
ed a refolding activity when combined with Hsp40. The
produced hHsp70 presented a refolding efficiency of 95 %.
Interestingly, this activity was twofold higher compared to the
commercially available hHsp70 (tagged). The delta-hHsp70
did not present any refolding activity. The lack of activity for
this properly folded truncated protein can be explained by (i)
the loss of dimerization ability, or (ii) the loss of an essential
part of the protein for its chaperone activity, or (iii) both. As
expected, the negative control presented a very low activity. In
these conditions, this assay demonstrates the refolding activity
(95 %) of the produced hHsp70.
Discussion
Validation of hHSP70 structure
In this paper, we report that hHsp70 can be expressed in
milligram quantities using E. coli. The decrease of the fluo-
rescence signal and the red shift of the emission frequency
when a chaotropic agent is mixed with hHsp70 in solution
support the quality of the purification. These modifications of
the fluorescence are typically associated with the denaturation
of a protein that was initially well-folded. The quantity of
purified protein allows for the characterization of the second-
ary structures by the deconvolution of the CD spectra; the
percentage of alpha-helix was estimated for the entire protein
to be approximately 50–60% and the percentage of beta-sheet
to be approximately 25–30 %. The percentage of alpha-helix
and beta-sheet estimated from the crystal structure of the
homolog E. coli DnaK are 36 and 27 %, respectively (PDB
ID: 2KHO) (Bertelsen et al. 2009). The proportion of second-
ary structure elements in hHsp70 and in E. coliDnaK are thus
in the same range. Our experimental data for hHsp70 supports
the previous model prediction of the secondary structure of
hHsp70 (Nicolaï et al. 2013). Sparse evidences of the oligo-
merization status of some Hsp70 family members are collated
in Table 1. In this study, the SEC-MALS analysis revealed a
monodisperse homodimeric hHsp70 with a very low percent
of aggregated forms. The BLI experiments clearly confirm
with another approach the dimeric state of the protein and
provides us with aKD in the low nanomolar range (KD ~5 nM)
for the interaction between the two hHsp70 proteins forming
the dimer.
Validation of hHsp70 activity
The activity of the purified protein was tested with a refolding
assay using firefly luciferase. The observed activity was 2 to 3
Fig. 6 Confirmation of the chaperone function with a firefly luciferase
refolding assay and ATPase activity assay. The bar diagram represents
the percentage of ATP to ADP hydrolysis (a): with no proteins (NP), with
native firefly luciferase (NL), or with denatured firefly luciferase (DL) in a
refolding buffer containing either no Hsps, our full-length hHsp70 alone,
hHsp40 alone, or the both Hsps. ADP formation was assessed by mea-
suring the loss of d2-ADP fluorescence at 665 nm, reported by cryptate
fluorescence at 620 nm after 1 h of incubation. The percentage of ATP to
ADP hydrolysis values are obtained from an ATP/ADP standard curve.
The Pareto plot represents the percentage of firefly luciferase refolding
(b) in the presence of the full-length hHsp70, delta-hHsp70 (detailed in
the present paper), and a commercially available hHsp70. The refolding
of luciferase after denaturation (0.2 M guanidinium-HCl for 30 min at
25 °C) was measured by collecting total light at 560 nm after 3 h of
incubation at 35 °C. Values are compared to a positive control (non-
denatured luciferase only, set to 100 % of refolding) and a negative
control (denatured luciferase incubated without Hsps)
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times higher compared to the commercially available His-
tagged hHsp70. This result is consistent with a previous
observation of activity alteration when hHsp70 is tagged
(Boice and Hightower 1997). The present results demonstrate
that the hHsp70 produced here adopts its full native state and
is fully functional as shown by its chaperone as well as its
ATPase activity.
C-terminal part involved in hHsp70 dimerization
The BLI data, measuring the binding of hHsp70 with the A17
ligand (Fig. 5), demonstrates a high-affinity as the A17:
hHsp70 interaction is around 6 nM. Besides, the comparison
of all available model fittings is consistent with the homodi-
meric nature of hHsp70. This third proof is indirect but com-
plementary to the two first evidences provided by the SEC-
MALS data and the BLI determination of hHsp70: hHsp70.
Interestingly, we used a previously selected peptide
aptamer (A17) for its ability to specifically bind to the N-
terminal domain of hHsp70, further supporting the role of the
C-terminal part in the dimerization. Although the N-terminal
domain is generally considered to be the most conserved
(compared to the C-terminal domain), our data enlightens
actual differences between human and bacterial Hsp70 N-
terminal regions (Aprile et al. 2013; Flaherty et al. 1990;
Hartl and Hayer-Hartl 2009; Schmid et al. 1994; Zhang and
Walker 1998).
Our peptide mass fingerprinting of the purified truncated
form combined with the SEC-MALS analysis demonstrates
the role of the C-terminal part in the dimerization (I562 to
D641). Interestingly, this protease sensitive region has been
previously reported for bovine Hsc70 (Chappell et al. 1987).
Our observations of another Hsp70 family member raise the
question of the physiological relevance of the truncation we
present here for hHsp70 (cleavage site databases such as
PeptideCutter and MEROPS did not allow us to identify a
highly sequence-specific protease). Interestingly, delta-
hHsp70 does not present chaperone activity. This observation
can be explained by the truncation of the C-terminal part
containing the EEVD motif. The EEVD motif has been dem-
onstrated to be necessary for the interaction with the folding
partner Hsp40 (Freeman et al. 1995). The C-terminal part
identified in the homodimerization present two cysteine resi-
dues. The full-length hHsp70 was observed at the same ap-
parent mass by SDS-PAGE when loading with or without
reductant dithiothreitol treatment (data not shown). Recently,
a study suggested the role of the interaction between the
interdomain linker and the SBD in the oligomerization pro-
cess (Aprile et al. 2013). This result together with our SDS-
PAGE observations is in contrast with a previous study show-
ing a disulfide bridge formed by cysteine 574 in the hHsp70
dimer (Nemoto et al. 2006). The last 80 C-terminal residues
have been demonstrated to be involved in dimerization.
Interestingly, the sequence identity of these 80 C-terminal
amino acids with DnaK is approximately 20 %, whereas the
global identity is calculated at 50 %. This observation warns
us to be careful in generalizing the results for DnaK as it
presents an EEVKD sequence, whereas hHsp70 bears the
EEVD motif.
Conclusion
In conclusion, this study provides strong evidence for the
homodimeric nature of hHsp70 and identifies the last 80 C-
terminal residues as involved in the dimerization process. Our
experiments revealed that the dimerization process is
governed by non-covalent interactions. As shown in the pres-
ent paper, it is possible to purify large quantities of full-length
non-tagged properly folded and active hHsp70, thereby open-
ing up the possibility of the biophysical/biochemical studies
presented in this study or radiocrystallography.
Although the physiological role of the hHsp70 homodimer
remains to be elucidated, its dimeric nature may be a way to
regulate its function, and potentially sets a new paradigm for
human Hsp70.
Materials and methods
Construction of the hHsp70 expression plasmid
A codon-optimized gene encoding for hHsp70 expression in
E. coli was synthesized (Geneart, Carlsbad, California). Nde1
and Sac1 restriction sites were inserted into the 5’ and 3’ ends,
respectively, of the open reading frame coding sequence for
hHsp70. The digested sequences were ligated in a pET21a
plasmid previously opened by the same restriction enzymes in
the cloning cassette. The resulting expression vector (pET21-
hHsp70) encodes a full-length hHsp70 translated in the fol-
lowing sequence:
MAKAAAIGIDLGTTYSCVGVFQHGKVEIIANDQG-
NRTTPSYVAFTDTERLIGDAAKNQVALNPQNTVFDA
KRLIGRKFGDPVVQSDMKHWPFQVINDGDKPKV
QVSYKGDTKAFYPEEISSMVLTKMKEIAEAYLGYPVT
NAVITVPAYFNDSQRQATKDAGVIAGLNVLRIINEP
TAAAIAYGLDRTGKGERNVLIFDLGGGTFDVSILTIDD
GIFEVKATAGDTHLGGEDFDNRLVNHFVEEFKR
KHKKDISQNKRAVRRLRTACERAKRTLSSSTQASLEI
DSLFEGIDFYTSITRARFEELCSDLFRSTLEPVEKALR
DAKLDKAQIHDLVLVGGSTRIPKVQKLLQDFFNGRD
LNKSINPDEAVAYGAAVQAAILMGDKSENVQDLLLL
DVAPLSLGLETAGGVMTALIKRNSTIPTKQTQIFTTYS
DNQPGVLIQVYEGERAMTKDNNLLGRFELSGI
PPAPRGVPQIEVTFDIDANGILNVTATDKSTGKANKIT
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ITNDKGRLSKEEIERMVQEAEKYKAEDEVQRERVSA
KNALESYAFNMKSAVEDEGLKGKISEADKKKVLDKC
QEVISWLDANTLAEKDEFEHKRKELEQVCNPIISGLY
QGAGGPGPGGF GAQGPKGGSGSGPTIEEVD
The integrity of the construct was verified by DNA
sequencing.
Production of hHsp70
BL21 Star™ (DE3), cells were transformed with the pET21-
hHsp70 plasmid. The selected clones obtained on agar Luria
broth (LB) plate supplemented with ampicillin (100 μg/L)
after cell transformation were used to inoculate a 100-mL
LB culture (100μg/L ampicillin). After 12 h, 20mL of culture
was transferred to 1 L of LB culture (100 μg/L ampicillin) and
incubated at 37 °C. Cell growth was stopped by centrifugation
at 4,000×g, 20 h after induction by 1 mM (final concentration)
IPTG.
Purification of hHsp70
After production and centrifugation, cells were resuspended in
buffer A (50 mM Tris–HCl, pH 8.0) supplemented with
20 μM of dithiothreitol. Cells were then disrupted by sonica-
tion at 4 °C and centrifuged at 17,000×g for 45 min at 4 °C.
The supernatant cell lysate was loaded onto an 80-mL DEAE-
Sepharose column (GE Healthcare). After washing with two
column volumes of buffer A, proteins were eluted by a KCl
linear gradient (0 to 1 M KCl in buffer A). A 40-mL Q-
Sepharose column and a Superdex 200 Hiload 26/60 (GE
healthcare, Little Chalfont, Buckinghamshire, UK) coupled
to an AKTA FPLC were used for the following purification
steps. Identical buffer, washing, and elution protocols were
used on the Q-Sepharose and the DEAE column. Separation
on the Superdex 200 was performed with an isocratic flow of
buffer A. The protein concentration before size exclusion
chromatography and after the last purification step was con-
ducted using an Amicon Ultra (Millipore) filter unit with a
cutoff of 10 kDa. The final pure protein fractions were pooled
and concentrated to approximately 100 μM and either directly
frozen at 20 °C or tested for activity. Purity of the proteins was
assessed using SDS-PAGE with Coomassie-blue staining.
Quantification of the full-length hHsp70 was determined
using UV spectroscopy with a molar extinction coefficient
of 33,350M−1 cm−1 at 280 nm, calculated from the amino acid
composition of the protein on ProtParam (http://web.expasy.
org/protparam/). The same method was used to determine a
molar extinction coefficient of 26,360 M−1 cm−1 at 280 nm,
based on the mass spectroscopy protein length estimation. The
theoretical isoelectric pH of the two forms was calculated
using the ProtParam tool (http://web.expasy.org/protparam/).
The purified and concentrated proteins at 10 μM were frozen
at 20 °C in a 50-mM Tris–HCl pH 8.0 buffer.
Intrinsic fluorescence measurement
Intrinsic fluorescence was measured using a Cary Eclipse
spectrofluorimeter (Varian Instruments) equipped with mag-
netic stirrers and a Peltier temperature control unit. All exper-
iments were conducted at 25 °C. The emission spectra were
recorded between 310 and 450 nm after excitation at 295 nm.
Both excitation and emission bandwidths were 5 nm. The
spectra were recorded in a 2-mL cuvette of 1 cm path-length
with a 5-μMprotein concentration in buffer A or buffer Awith
2 and 4 M guanidine chloride.
Far-UV circular dichroism
Far-UV circular dichroïsm (CD) spectra were recorded using a
JASCO J-815 spectropolarimeter equipped with a Peltier tem-
perature control set at 25 °C. Using a 0.01-cm path-length
quartz cell (Hellma), the protein samples spectra (5 μM in
20 mM Tris–HCl pH 8.0) were recorded with a scan speed of
50 nm.min−1 between 188 and 260 nm. Spectra were averaged
over 10 scans and corrected by subtraction of the spectra
acquired for buffer (20 mM Tris–HCl, pH 8.0) alone. CD
measurements were normalized to protein concentration and
presented as molar ellipticity deg.cm2.dmol−1 using the Jasco
Spectra Analysis software. The spectra were decomposed to
α-helix, β-sheet, β-turn, and random coil elements using
Yang’s reference set (Venyaminov et al. 1993).
Peptide mass fingerprinting
Purified protein band sequences were identified by peptide
mass fingerprinting using tryptic cleavage combined with
MALDI-ToF analysis. After purification, the full-length or
the truncated forms of hHsp70 were loaded on SDS-PAGE.
The corresponding bands were cut and extracted from the gel.
After reduction and alkylation, theywere digestedwith 100 ng
of pig trypsin (PROMEGA). The peptides were injected on a
LC-MS orbitrap. The PAPPSO platform (INRA, Jouy-en-
Josas) was employed to conduct the protein identification
using MS-Fit (Protein Prospector, UCSF).
Size exclusion chromatography with on-line multi-angle light
scattering (SEC-MALS)
The investigation of protein oligomeric states was performed
on a Jasco PU-2080 Plus system consisting of a pump, a
vacuum degasser, an autosampler, and a silica column
MP015S5 or MP030S5 (7.8 mm, 300 mm), (Wyatt, Santa
Barbara, CA). The MP015S5 column was used for the
hHsp70 monomer, whereas the MP030S5 column was used
for the hHsp70 dimer. The detection was carried out using a
refractometer (RID-10A, Shimadzu) and a miniDAWN
TREOS light scattering detector (Wyatt Technology). The
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column temperature was regulated at 20 °C. The buffer used
for the isocratic gradient at 0.5 mL/min was a 0.1-M sodium
phosphate buffer at pH 7.0. The 90° detector of the
miniDAWN TREOS was calibrated using a toluene solution,
the other detectors (45° and 135°) were normalized using a 10-
mg/mL BSA solution in 0.1 M phosphate buffer, pH 7.0. The
toluene calibration of the system was confirmed for different
molecular sizes and oligomeric states of known proteins.
The solute concentration (C) was obtained directly from
the refractive index signal for each volume slice according to
C=(Vi K)/(dn/dc), where Vi is the detector output voltages for
volume slice i, and K is the calibration constant. A dn/dc value
of 0.186 mL/g was used for the calculations. The molecular
mass of the protein was computed using the ASTRAV soft-
ware (Wyatt Technology, Santa Barbara, CA, USA) based on
the light scattering and refractive index signals.
Bio-Layer Interferometry
Bio-layer interferometry (BLI), an optical and label-free tech-
nique sensitive to an increase of mass bound to the biosensor
(e.g., bound analyte), provides sensorgrams as surface plas-
mon resonance. The first BLI experiment (Fig. 4), measures
the affinity of the interacting protein. In a first step, the
proteins (5 μg of biotinylated hHsp70 or DnaK) were incu-
bated in a PBS buffer with a 1:3 ratio molar ratio of biotin. The
free biotin was removed using a desalting column (Pierce).
Then, the biotinylated protein was immobilized onto
streptavidin biosensor tips and dipped into wells containing
the analyte at different concentrations in PBS: hHsp70 (200,
300, 400, and 500 nM); hHsp40 (20, 30, 40, and 50 nM); and
DnaK (200, 300, 400, and 500 nM). The second BLI exper-
iment (Fig. 5) allowed the measurement of the dimeric
hHsp70 interaction with a specific ligand. A17 binds to the
N-terminal region of hHsp70 (Rerole et al. 2011; Seigneuric
et al. 2011a) and was biotinylated with a 1:3 ratio (biotin-
PEG4-NHS from Pierce EZ kit, prepared following the man-
ufacturer’s instructions). The free biotin was removed using a
desalting column (Pierce), then, the biotinylated ligand (A17)
was immobilized onto streptavidin biosensor tips and dipped
into wells containing the analyte (hHsp70 or DnaK at 100 nM
in PBS). Both experiments (total volume in each well:
200 μL; shake speed: 1,000 rpm, association phase: 600 s;
dissociation phase: 600 s) were background corrected,
smoothed with the Savitzky-Golay algorithm and analyzed
using OctetRED instrument software (ForteBio Data Analysis
version 7.1.). For the first experiment (Fig. 4), all sensograms
were fit with a 1:1 model. For the second type of experiment
(Fig. 5), all available models were tested; but only the 1:2
model (bivalent analyte) was matching for the A17:hHsp70
interaction (excluding a 1:1 model). However, for the
A17:DnaK interaction, the 1:1 model was matching (not
excluding a more complex 1:2 model).
hHsp70 ATPase activity assay
Firefly luciferase was denatured with 6 M guanidium-HCl,
and then incubated with ATP (100 μM) and/or Hsp40
(160 nM) and/or hHsp70 (800 nM) for an hour. ATP to
ADP conversion was monitored using the HTRF transcreener
ADP (Cisbio assays, Codolet, France), according to the man-
ufacturer’s instruction. Briefly, after refolding, 10 μL of
refolding mix was incubated for 1 h with 37.5 μL 1X HTRF
transcreener ADP enzymatic buffer, 5 μL of Anti-ADP anti-
body coupled to the HTRF donor Eu3+ cryptate, and 5 μL of
d2-coupled ADP acceptor. ATP hydrolysis to native ADP will
compete with d2-coupled ADP, inducing a loss of fluores-
cence transfert from the anti-ADP cryptate conjugated anti-
body to the d2 acceptor. Native ADP formation was thus
assessed by measuring the decrease in d2-coupled ADP fluo-
rescence at 665 nm, reported to the increase in cryptate emis-
sion at 620 nm, using a Wallac 1420 VICTOR3 luminometer.
Delta F were obtained by calculating 10,000×the 665/625
ratio, and total ATP conversion was obtained by comparing
with Delta F distribution of an ATP/ADP standard curve that
mimics the reaction (with total adenosine remaining constant
throughout the range).
hHsp70 refolding assay
Firefly luciferase (10 μM, Sigma-Aldrich) was denatured with
0.2 M guanidinium-HCl for 30 min at 25 °C. Refolding of the
denatured luciferase (80 nM) at 35 °C was monitored during
3 h in the presence of ATP (1 mM) and/or Hsp40 (160 nM)
and/or hHsp70 (800 nM) (i.e., the full-length or truncated
forms produced by us or from Stressgen). Finally, D-
luciferin (0.25 mM) was added, and after 10 min, the percent-
age of refolded luciferase was measured by collecting total
light at 560 nm by aWallac 1420 VICTOR3 luminometer. The
positive control (non-denatured luciferase) was set to 100 %.
The negative control consists of denatured luciferase in the
folding buffer without Hsps. The guanidinium concentration
used for the denaturation and the time used for the refolding
were optimized for refolding efficiency.
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